Vanderbilt eskind diabetes clinic

Shichun Bao, MD, PhD, center, and Brenda Weedman, RN, BSN, discuss continuous glucose monitors with patient Sherry Neergaard.

Study shows continuous glucose monitors improve management of type 2 diabetes

For patients with type 2 diabetes treated with basal or long-acting insulin, the use of continuous glucose monitors (CGMs) can result in significantly lower hemoglobin A1C (a blood test that reflects average blood glucose levels over three months), and better management of the disease according to a study recently published in the journal JAMA.

Fourth-year VUSM student Emily Long assists Paul Epstein, MD, as he conducts telehealth visits with patients of the Vanderbilt Eskind Diabetes Clinic.

VUSM students help patients, clinicians with telehealth

When in-person visits to Vanderbilt Eskind Diabetes Clinic needed to be quickly converted to telehealth appointments in response to COVID-19, a novel solution was hatched to bring both clinicians and patients up to speed on videoconferencing.

Renovated Eskind Biomedical Library reopened

The Annette and Irwin Eskind Family Biomedical Library and Learning Center opened July 18 after a yearlong, $12.9 million renovation with infrastructure improvements and updates to support the continuing evolution of medical education.

New diabetes technology clinic informs patients about innovations

Shichun Bao, M.D., Ph.D., associate professor of Medicine, unclips an insulin pump smaller than a deck of cards from her waistband to glance at its digital readout — but she doesn’t actually have diabetes and the pump contains only saline.

Eskind family makes $6 million gift to keep library on leading edge of health education innovation

A visionary $6 million gift to Vanderbilt from the Eskind family ensures that the Eskind Biomedical Library will support the next generation of scientists, physicians, students and patients.

New tool in fight against pediatric diabetic retinopathy

The Children’s Diabetes Program at Monroe Carell Jr. Children’s Hospital at Vanderbilt recently unveiled its latest tool in helping to prevent diabetic retinopathy, the leading cause of acquired blindness in the United States.

1 2